SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-135333
Filing Date
2021-11-08
Accepted
2021-11-08 07:32:56
Documents
16
Period of Report
2021-11-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132125d1_8k.htm   iXBRL 8-K 31322
2 EXHIBIT 3.1 tm2132125d1_ex3-1.htm EX-3.1 17015
3 EXHIBIT 3.2 tm2132125d1_ex3-2.htm EX-3.2 114845
4 EXHIBIT 99.1 tm2132125d1_ex99-1.htm EX-99.1 13954
  Complete submission text file 0001104659-21-135333.txt   430135

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kprx-20211105.xsd EX-101.SCH 3278
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kprx-20211105_def.xml EX-101.DEF 26644
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20211105_lab.xml EX-101.LAB 36628
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20211105_pre.xml EX-101.PRE 25299
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2132125d1_8k_htm.xml XML 5251
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 211386528
SIC: 2834 Pharmaceutical Preparations